- Investopedia•38 minutes ago
Credit Suisse says Pfizer could find Bristol-Myers attractive.
- Investor's Business Daily•2 hours ago
Pfizer could boost its value by $5 billion in a takeover of Bristol-Myers, an analyst said Monday.
- Investopedia•2 hours ago
Pfizer's Xeljanz got marketing approval from the EC, both as a monotherapy and as a combo therapy.
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||33.75 - 34.31|
|52 Week Range||29.41 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.21|
|Dividend & Yield||1.28 (3.76%)|
|1y Target Est||N/A|